Does the fetal hypothalamus have the potential to generate cells with a gonadotropin releasing hormone ( GnRH ) phenotype?
This in vitro model should be useful to study the molecular mechanisms involved in GnRH neuronal differentiation.
The results of the present study validate the use of EEAV to treat neuropathic pain. This effect may be attributed to the decreased migration of neutrophils and due to the anti-oxidant properties of A. vera. Further studies to confirm the mechanism of action will help develop suitable A. vera formulations for neuropathic pain therapy.